These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 22461131

  • 1. Coexpression of stemness factors Oct4 and Nanog predict liver resection.
    Yin X, Li YW, Zhang BH, Ren ZG, Qiu SJ, Yi Y, Fan J.
    Ann Surg Oncol; 2012 Sep; 19(9):2877-87. PubMed ID: 22461131
    [Abstract] [Full Text] [Related]

  • 2. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X, Zhang BH, Zheng SS, Gao DM, Qiu SJ, Wu WZ, Ren ZG.
    J Hematol Oncol; 2015 Mar 11; 8():23. PubMed ID: 25879771
    [Abstract] [Full Text] [Related]

  • 3. Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression.
    Chang TS, Wu YC, Chi CC, Su WC, Chang PJ, Lee KF, Tung TH, Wang J, Liu JJ, Tung SY, Kuo LM, Ho HN, Ling TY, Huang YH.
    Clin Cancer Res; 2015 Jan 01; 21(1):201-10. PubMed ID: 25564572
    [Abstract] [Full Text] [Related]

  • 4. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.
    Ann Surg Oncol; 2012 Oct 01; 19(11):3556-65. PubMed ID: 22588469
    [Abstract] [Full Text] [Related]

  • 5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P, Jin J, Liao Y, Li J, Yu XZ, Liao W, He S.
    Oncotarget; 2015 Dec 01; 6(38):41383-97. PubMed ID: 26515591
    [Abstract] [Full Text] [Related]

  • 6. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC.
    Int J Cancer; 2004 Oct 20; 112(1):44-50. PubMed ID: 15305374
    [Abstract] [Full Text] [Related]

  • 7. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
    Zheng H, Yang Y, Wang MC, Yuan SX, Tian T, Han J, Ni JS, Wang J, Xing H, Zhou WP.
    Surg Oncol; 2016 Sep 20; 25(3):171-7. PubMed ID: 27566019
    [Abstract] [Full Text] [Related]

  • 8. Increased expression of OCT4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma.
    Dong Z, Zeng Q, Luo H, Zou J, Cao C, Liang J, Wu D, Liu L.
    Pathol Res Pract; 2012 Sep 15; 208(9):527-33. PubMed ID: 22824146
    [Abstract] [Full Text] [Related]

  • 9. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
    Cheng SW, Tsai HW, Lin YJ, Cheng PN, Chang YC, Yen CJ, Huang HP, Chuang YP, Chang TT, Lee CT, Chao A, Chou CY, Chan SH, Chow NH, Ho CL.
    PLoS One; 2013 Sep 15; 8(11):e80053. PubMed ID: 24244607
    [Abstract] [Full Text] [Related]

  • 10. Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Tsuchiya K, Komuta M, Yasui Y, Tamaki N, Hosokawa T, Ueda K, Kuzuya T, Itakura J, Nakanishi H, Takahashi Y, Kurosaki M, Asahina Y, Enomoto N, Sakamoto M, Izumi N.
    Oncology; 2011 Sep 15; 80(3-4):278-88. PubMed ID: 21734420
    [Abstract] [Full Text] [Related]

  • 11. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD.
    World J Gastroenterol; 2015 Jun 07; 21(21):6649-59. PubMed ID: 26074703
    [Abstract] [Full Text] [Related]

  • 12. [OCT4 expression in hepatocellular carcinoma and its clinical significance].
    Huang PZ, Lu CL, Li BK, Hong J, Huang L, Wang L, Zhang Y, Yuan YF.
    Chin J Cancer; 2010 Jan 07; 29(1):111-16. PubMed ID: 20038322
    [Abstract] [Full Text] [Related]

  • 13. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G, Chen JH, Qiang Y, Wang DZ, Chen Z.
    World J Gastroenterol; 2015 Apr 07; 21(13):3983-93. PubMed ID: 25852285
    [Abstract] [Full Text] [Related]

  • 14. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
    Chen R, Cui J, Xu C, Xue T, Guo K, Gao D, Liu Y, Ye S, Ren Z.
    Ann Surg Oncol; 2012 Jul 07; 19 Suppl 3():S375-84. PubMed ID: 21681378
    [Abstract] [Full Text] [Related]

  • 15. Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
    Wang ZS, Wu LQ, Yi X, Geng C, Li YJ, Yao RY.
    BMC Cancer; 2013 Jun 24; 13():306. PubMed ID: 23800357
    [Abstract] [Full Text] [Related]

  • 16. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
    Chang TS, Chen CL, Wu YC, Liu JJ, Kuo YC, Lee KF, Lin SY, Lin SE, Tung SY, Kuo LM, Tsai YH, Huang YH.
    PLoS One; 2016 Jun 24; 11(2):e0149897. PubMed ID: 26919045
    [Abstract] [Full Text] [Related]

  • 17. Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.
    Rasti A, Mehrazma M, Madjd Z, Abolhasani M, Saeednejad Zanjani L, Asgari M.
    Sci Rep; 2018 Aug 06; 8(1):11739. PubMed ID: 30082842
    [Abstract] [Full Text] [Related]

  • 18. The prognostic value of combination of CD90 and OCT4 for hepatocellular carcinoma after curative resection.
    Zhao RC, Zhou J, Chen KF, Gong J, Liu J, He JY, Guan P, Li B, Qin Y.
    Neoplasma; 2016 Aug 06; 63(2):288-98. PubMed ID: 26674131
    [Abstract] [Full Text] [Related]

  • 19. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
    Tsai LL, Yu CC, Chang YC, Yu CH, Chou MY.
    J Oral Pathol Med; 2011 Sep 06; 40(8):621-8. PubMed ID: 21342274
    [Abstract] [Full Text] [Related]

  • 20. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
    Wang ZS, Wu LQ, Yi X, Geng C, Li YJ, Yao RY, Hu WY, Han B.
    Zhonghua Zhong Liu Za Zhi; 2012 Oct 06; 34(10):753-8. PubMed ID: 23291069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.